.Merck beats incomes assumptions, rears sales overview on sturdy demand for leading medications like Keytruda CNBCMerck & Co. (MRK US) Beats Revenue Estimates as Keytruda Purchases Rise BloombergMerck Supply: Pharma Titan Posts Tough Outcomes, Yet Expectation Tumbles Short Financier's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats earnings as well as purchases requirements among Keytruda strong point, yet delivers blended full-year outlook MarketWatch.